Up-regulation of long non-coding RNA AB073614 predicts a poor prognosis in patients with glioma

International Journal of Environmental Research and Public Health

Volumn 13, Issue 4, 2016, Pages

  Hu, Lei ^a   Lv, Qiao Li ^a   Chen, Shu Hui ^b   Sun, Bao ^a   Qu, Qiang ^a   Cheng, Lin ^c   Guo, Ying ^a   Zhou, Hong Hao ^a   Fan, Lan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CHANGSHA CENTRAL HOSPITAL   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

AB073614; Glioma; Long non coding RNA; Prognostic biomarker

Indexed keywords

LONG NONCODING RNA AB073614; LONG UNTRANSLATED RNA; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

BIOMARKER; CANCER; GENETIC ANALYSIS; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RNA; TUMOR;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PREDICTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; UPREGULATION; AGED; BRAIN TUMOR; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; ODDS RATIO; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA, LONG NONCODING; UP-REGULATION;

EID: 84964284816     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13040433     Document Type: Article

References (38)

1. Wen, P.Y.; Kesari, S. Malignant gliomas in adults. N. Eng. J. Med. 2008, 359, 492–507. [CrossRef] [PubMed]
2. Louis, D.N.; Ohgaki, H.; Wiestler, O.D.; Cavenee, W.K.; Burger, P.C.; Jouvet, A.; Scheithauer, B.W.; Kleihues, P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114, 97–109. [CrossRef] [PubMed]
3. Omuro, A.; DeAngelis, L.M. Glioblastoma and other malignant gliomas: A clinical review. JAMA 2013, 310, 1842–1850. [CrossRef] [PubMed]
4. Eckel-Passow, J.E.; Lachance, D.H.; Molinaro, A.M.; Walsh, K.M.; Decker, P.A.; Sicotte, H.; Pekmezci, M.; Rice, T.; Kosel, M.L.; Smirnov, I.V.; et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N. Eng. J. Med. 2015, 372, 2499–2508. [CrossRef] [PubMed]
5. Wollmann, G.; Ozduman, K.; van den Pol, A.N. Oncolytic virus therapy for glioblastoma multiforme: Concepts and candidates. Cancer J. 2012, 18, 69–81. [CrossRef] [PubMed]
6. Chen, Y.; Wu, J.J.; Lin, X.B.; Bao, Y.; Chen, Z.H.; Zhang, C.R.; Cai, Z.; Zhou, J.Y.; Ding, M.H.; Wu, X.J.; et al. Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray analysis. Int. J. Clin. Exp. Med. 2015, 8, 5033–5043. [PubMed]
7. Kraus, T.F.; Greiner, A.; Guibourt, V.; Lisec, K.; Kretzschmar, H.A. Identification of Stably Expressed lncRNAs as Valid Endogenous Controls for Profiling of Human Glioma. J. Cancer 2015, 6, 111–119. [CrossRef] [PubMed]
8. Li, F.; Cao, L.; Hang, D.; Wang, F.; Wang, Q. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma. Int. J. Clin. Exp. Pathol. 2015, 8, 11414–11420. [PubMed]
9. Liu, Y.; Zhang, M.; Liang, L.; Li, J.; Chen, Y.X. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer. Int. J. Clin. Exp. Pathol. 2015, 8, 11480–11484. [PubMed]
10. Xu, S.P.; Zhang, J.F.; Sui, S.Y.; Bai, N.X.; Gao, S.; Zhang, G.W.; Shi, Q.Y.; You, Z.L.; Zhan, C.; Pang, D. Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer. Tumour Biol. 2015, 36, 9807–9812. [CrossRef] [PubMed]
11. Zhu, S.; Mao, J.; Shao, Y.; Chen, F.; Zhu, X.; Xu, D.; Zhang, X.; Guo, J. Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance. Tumour Biol. 2015, 36, 8041–8045. [CrossRef] [PubMed]
12. Fei, Z.H.; Yu, X.J.; Zhou, M.; Su, H.F.; Zheng, Z.; Xie, C.Y. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer. Tumour Biol. 2015, 9. [CrossRef] [PubMed]
13. Peng, W.; Wu, G.; Fan, H.; Wu, J.; Feng, J. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer. Tumour Biol. 2015, 36, 6751–6758. [CrossRef] [PubMed]
14. Yang, Y.; Shao, Y.; Zhu, M.; Li, Q.; Yang, F.; Lu, X.; Xu, C.; Xiao, B.; Sun, Y.; Guo, J. Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer. Tumour Biol. 2015, 8. [CrossRef] [PubMed]
15. Zhao, X.L.; Zhao, Z.H.; Xu, W.C.; Hou, J.Q.; Du, X.Y. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Int. J. Clin. Exp. Pathol. 2015, 8, 1954–1960. [PubMed]
16. Zeng, Z.; Bo, H.; Gong, Z.; Lian, Y.; Li, X.; Li, X.; Zhang, W.; Deng, H.; Zhou, M.; Peng, S.; et al. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis. Tumour Biol. 2015, 8. [CrossRef] [PubMed]
17. Qureshi, I.A.; Mehler, M.F. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat. Rev. Neurosci. 2012, 13, 528–541. [CrossRef] [PubMed]
18. Lu, S.; Wang, S.; Geng, S.; Ma, S.; Liang, Z.; Jiao, B. Upregulation of microRNA-224 confers a poor prognosis in glioma patients. Clin. Transl. Oncol. 2013, 15, 569–574. [CrossRef] [PubMed]
19. Zhang, X.; Dong, X.H.; Ma, Y.; Li, L.F.; Wu, H.; Zhou, M.; Gu, Y.H.; Li, G.Z.; Wang, D.S.; Zhang, X.F.; et al. Reduction of _-dystroglycan expression is correlated with poor prognosis in glioma. Tumour Biol. 2014, 35, 11621–11629. [CrossRef] [PubMed]
20. Ma, K.X.; Wang, H.J.; Li, X.R.; Li, T.; Su, G.; Yang, P.; Wu, J.W. Long non-coding RNA MALAT1 associates with the malignant status and poor prognosis in glioma. Tumour Biol. 2015, 36, 3355–3359. [CrossRef] [PubMed]
21. Zhang, K.; Sun, X.; Zhou, X.; Han, L.; Chen, L.; Shi, Z.; Zhang, A.; Ye, M.; Wang, Q.; Liu, C.; et al. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner. Oncotarget 2015, 6, 537–546. [CrossRef] [PubMed]
22. Wang, P.; Ren, Z.; Sun, P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J. Cell Biol. Chem. 2012, 113, 1868–1874. [CrossRef] [PubMed]
23. Shi, Y.; Wang, Y.; Luan, W.; Wang, P.; Tao, T.; Zhang, J.; Qian, J.; Liu, N.; You, Y. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS ONE 2014, 9, e86295. [CrossRef] [PubMed]
24. Wang, P.; Liu, Y.H.; Yao, Y.L.; Li, Z.; Li, Z.Q.; Ma, J.; Xue, Y.X. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal. 2015, 27, 275–282. [CrossRef] [PubMed]
25. Cheng, Z.; Guo, J.; Chen, L.; Luo, N.; Yang, W.; Qu, X. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer. Oncotarget 2015, 6, 25381–25389. [CrossRef] [PubMed]
26. Mercer, T.R.; Dinger, M.E.; Mattick, J.S. Long non-coding RNAs: Insights into functions. Nat. Rev. Genet. 2009, 10, 155–159. [CrossRef] [PubMed]
27. Zhang, T.; Cao, C.; Wu, D.; Liu, L. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma. Tumour Biol. 2015, 16. [CrossRef] [PubMed]
28. Zhang, H.; Zhao, L.; Wang, Y.X.; Xi, M.; Liu, S.L.; Luo, L.L. Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma. Tumour Biol. 2015, 36, 8805–8809. [CrossRef] [PubMed]
29. Wang, Y.L.; Bai, Y.; Yao, W.J.; Guo, L.; Wang, Z.M. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamouscell carcinoma and its correlation with tumor progression and patient survival. Int. J. Clin. Exp. Pathol. 2015, 8, 11871–11876. [PubMed]
30. Li, J.; Zhang, M.; An, G.; Ma, Q. LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis. Exp. Biol. Med. 2016, 241, 644–649. [CrossRef] [PubMed]
31. Qin, X.; Yao, J.; Geng, P.; Fu, X.; Xue, J.; Zhang, Z. LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma. Int. J. Clin. Exp. Pathol. 2014, 7, 3065–3072. [PubMed]
32. Zhang, X.Q.; Leung, G.K. Long non-coding RNAs in glioma: Functional roles and clinicalperspectives. Neurochem. Int. 2014, 77, 78–85. [CrossRef] [PubMed]
33. Kiang, K.M.; Zhang, X.Q.; Leung, G.K. Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis. Cancers 2015, 7, 1406–1424. [CrossRef] [PubMed]
34. Yan, Y.; Zhang, L.; Jiang, Y.; Xu, T.; Mei, Q.; Wang, H.; Qin, R.; Zou, Y.; Hu, G.; Chen, J.; et al. LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human glioblastomamultiforme. J. Cancer Res. Clin. Oncol. 2015, 141, 827–838. [CrossRef] [PubMed]
35. Wang, Y.; Li, J.; Zhang, Y.; Yin, H.; Han, B. CRNDE, a long non-coding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett. 2015, 367, 122–128. [CrossRef] [PubMed]
36. Wang, Q.; Zhang, J.; Liu, Y.; Zhang, W.; Zhou, J.; Duan, R.; Pu, P.; Kang, C.; Han, L. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-primeend of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett. 2016, 373, 251–259. [CrossRef] [PubMed]
37. Li, R.; Qian, J.; Wang, Y.Y.; Zhang, J.X.; You, Y.P. Long noncoding RNA profiles reveal three molecular subtypes in glioma. CNS Neurosci. Ther. 2014, 20, 339–343. [CrossRef] [PubMed]
38. Yamada, S.; Ohira, M.; Horie, H.; Ando, K.; Takayasu, H.; Suzuki, Y.; Sugano, S.; Hirata, T.; Goto, T.; Matsunaga, T.; et al. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: Identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene 2004, 23, 5901–5911. [CrossRef] [PubMed]